2/19
07:25 am
cgem
Cullinan Therapeutics (NASDAQ:CGEM) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
High
Report
Cullinan Therapeutics (NASDAQ:CGEM) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
2/17
10:03 am
cgem
Rating for CGEM
Medium
Report
Rating for CGEM
2/17
10:03 am
cgem
Rating for CGEM
Medium
Report
Rating for CGEM
2/17
07:17 am
cgem
Cullinan Therapeutics (NASDAQ:CGEM) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
Medium
Report
Cullinan Therapeutics (NASDAQ:CGEM) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
2/17
05:58 am
cgem
Cullinan Therapeutics initiated with a Buy at Citi
Medium
Report
Cullinan Therapeutics initiated with a Buy at Citi
2/4
06:43 am
cgem
Cullinan Therapeutics (NASDAQ:CGEM) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
Medium
Report
Cullinan Therapeutics (NASDAQ:CGEM) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
2/4
06:43 am
cgem
Cullinan Therapeutics (NASDAQ:CGEM) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
Medium
Report
Cullinan Therapeutics (NASDAQ:CGEM) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
2/2
09:31 am
cgem
Rating for CGEM
Medium
Report
Rating for CGEM
2/2
09:31 am
cgem
Rating for CGEM
Medium
Report
Rating for CGEM
2/2
04:49 am
cgem
Cullinan Therapeutics initiated with a Buy at Guggenheim
Medium
Report
Cullinan Therapeutics initiated with a Buy at Guggenheim
2/2
04:49 am
cgem
Cullinan Therapeutics initiated with a Buy at Guggenheim
Medium
Report
Cullinan Therapeutics initiated with a Buy at Guggenheim
2/1
08:16 pm
cgem
Cullinan Therapeutics (NASDAQ:CGEM) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Medium
Report
Cullinan Therapeutics (NASDAQ:CGEM) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
2/1
08:16 pm
cgem
Cullinan Therapeutics (NASDAQ:CGEM) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Medium
Report
Cullinan Therapeutics (NASDAQ:CGEM) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
2/1
07:19 pm
cgem
Cullinan Therapeutics initiated with a Buy at Guggenheim
Medium
Report
Cullinan Therapeutics initiated with a Buy at Guggenheim
2/1
07:19 pm
cgem
Cullinan Therapeutics initiated with a Buy at Guggenheim
Medium
Report
Cullinan Therapeutics initiated with a Buy at Guggenheim
1/8
10:57 am
cgem
Cullinan Therapeutics (NASDAQ:CGEM) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Cullinan Therapeutics (NASDAQ:CGEM) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/8
08:02 am
cgem
Cullinan Therapeutics (NASDAQ:CGEM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Cullinan Therapeutics (NASDAQ:CGEM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
1/8
08:02 am
cgem
Cullinan Therapeutics (NASDAQ:CGEM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Cullinan Therapeutics (NASDAQ:CGEM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
12/9
08:16 am
cgem
Rating for CGEM
Low
Report
Rating for CGEM
12/9
08:16 am
cgem
Rating for CGEM
Low
Report
Rating for CGEM